Private equity-owned air ambulances receive higher payments, generate larger and more frequent surprise bills Loren Adler, Conrad Milhaupt, Erin Trish, and Bich Ly Tuesday, November 16, 2021
Addressing the trade-off between lower drug prices and incentives for pharmaceutical innovation Rena Conti, Richard G. Frank, and Jonathan Gruber Monday, November 15, 2021
How would filling the Medicaid “coverage gap” affect hospital finances? Matthew Fiedler Thursday, November 4, 2021
From vision to design in advancing Medicare payment reform J. Michael McWilliams, Alice Chen, and Michael E. Chernew Wednesday, October 13, 2021
Private equity investment as a divining rod for market failure: Policy responses to harmful physician practice acquisitions Erin C. Fuse Brown, Loren Adler, Erin Duffy, Paul B. Ginsburg, Mark Hall, and Samuel Valdez Tuesday, October 5, 2021
Changes in emergency physician service prices after Connecticut’s 2016 surprise billing law Loren Adler, Erin Duffy, Bich Ly, Conrad Milhaupt, and Erin Trish Thursday, September 23, 2021
Options for containing the cost of a new Medicare dental, hearing, and vision benefit Matthew Fiedler Friday, September 10, 2021
A framework for categorizing and analyzing prescription drug pricing reform options Rachel Sachs, Loren Adler, and Paul B. Ginsburg Tuesday, August 31, 2021
Government regulated or negotiated drug prices: Key design considerations Paul B. Ginsburg and Steven M. Lieberman Monday, August 30, 2021
